Beyond ‘surviving’ with HIV: living proof of why the paradigm must change
News
26 July 2017

Beyond ‘surviving’ with HIV: living proof of why the paradigm must change

At the meeting of the HIV Outcomes initiative on 1 June, Mario Cascio (EATG member and Steering Committee member of ‘Ageing with HIV’), gave a personal account of what it means to age with HIV. Significantly, he noted that the greatest discrimination he has faced has been within the context of the health system itself, for example when he was advised not to have children. Mario’s son is now an adult, and he describes being a father as the best experience of his life. Following the meeting, Professor Jeffrey Lazarus (HIV Outcomes co-chair) spoke with Mario to hear more about his experiences and why our collective way of thinking about HIV needs to change. “Beyond ‘surviving’ with HIV: living proof of why the paradigm must change” can be accessed here.

More updates All

Press Releases
29 November 2017
Brussels, 29 November 2017: Experts unveiled a set of recommendations on Wednesday to address health problems facing people living with HIV. Treatments are helping people with HIV live long lives, but they face higher risk than others of serious illnesses – from cancer ...
More
News
24 July 2017
HIV Outcomes steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, UK) will present an abstract of the initiative’s work at the 9th IAS Conference on HIV Science in Paris on 23-26 July 2017. Entitled ‘Are health systems ...
More
News
01 June 2017
Brussels, 1 June 2017: More people than ever before are living with HIV and they are living longer. However, they face multiple, complex health challenges that our healthcare systems have yet to adequately address. The HIV Outcomes initiative, a collaboration of patients, ...
More
Filters
Initiative Partners
  • Aids Action Europe
  • AFEW International
  • East Europe and Central Asia Union of PLWH
  • European AIDS Treatment Group
  • Gilead
  • ViiV Healthcare
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.